Are antidepressants really just about serotonin? In this episode, we dig into the science, the myths, and the messy truth behind SSRIs — the world’s most prescribed mental health medications.

In this episode of Your Mom on Drugs, we explore how Selective Serotonin Reuptake Inhibitors (SSRIs) became the cornerstone of modern mental health treatment. From their scientific origins in the 1980s to their widespread use today for depression, anxiety, OCD, and PTSD, we break down how these drugs work, what makes them effective, and why serotonin alone doesn’t tell the whole story.

Drawing on clinical research and patient experience, we compare SSRIs to psychotherapy, exercise, and other antidepressant classes, unpacking when each approach works best — and when it doesn’t. We also tackle common myths: whether SSRIs are addictive, personality-changing, or “quick fixes.” By the end, you’ll understand how these medications fit into a bigger picture of brain health, emotional healing, and holistic recovery.

In this episode, we take a deep dive into the fascinating and tightly regulated world of pharmaceutical manufacturing in the United States. From the initial research and development phases to the final quality control and packaging of medications, we explore how pharmaceutical companies ensure that every pill, capsule, or injection contains exactly what the label says—nothing more, nothing less. We’ll unpack how Good Manufacturing Practices (cGMP) and New Drug Applications (NDAs) are crucial for drug safety, and revisit pivotal moments in U.S. history, like the tragic sulfanilamide disaster, that shaped modern drug laws and FDA oversight.

We also shine a light on the lesser-known but vital role of compounding pharmacies. Whether tailoring a dose for a child, reformulating a drug for someone with allergies, or responding to shortages, compounders offer personalized solutions outside the mass-manufacturing model. But these benefits come with risks—especially in the case of sterile compounding, where contamination can have deadly consequences. We examine the difference between 503A and 503B compounding facilities, discuss notorious cases like the 2012 fungal meningitis outbreak, and explore how some pharmacies operate in regulatory gray zones. Tune in for a grounded, eye-opening conversation with my mom about the complex ecosystem behind the medications we often take for granted.

In this episode, we explore the fascinating world of adaptogens—a class of herbs, roots, and mushrooms long celebrated in traditional medicine systems like Ayurveda and Traditional Chinese Medicine, and now rising stars in the Western wellness scene. Marketed as natural tools to help the body “adapt” to stress, boost energy, and restore balance, adaptogens like ashwagandha, ginseng, and rhodiola have become staples in teas, capsules, and Instagram ads alike. But do they actually work? We dive into the origins of adaptogens, the science behind how they’re supposed to support the body’s stress response (particularly via the HPA axis), and why they’ve become a $10 billion industry—with all the buzz and baggage that entails.

From ancient healing rituals to modern supplement shelves, we break down the myths, mechanisms, and market trends behind adaptogens. We look at which herbs show the most promising effects, which claims are backed by data (and which aren’t), and what to watch out for in terms of side effects and drug interactions. Whether you’re a health skeptic, a supplement fan, or someone just trying to stay sane in a stressful world, this episode brings a grounded, evidence-based look at what adaptogens can—and can’t—do for your body and mind.

This episode tackles the nuanced debate surrounding vaping, weighing its potential benefits against its risks. While vaping is often portrayed as a safer alternative to traditional smoking, skepticism remains due to the presence of harmful chemicals in e-cigarette aerosol and the addictive nature of nicotine. The episode explores the complexities of research on vaping-related health risks, such as cardiovascular disease, and discusses how unrealistic lab conditions may sometimes overstate its dangers. Additionally, we delve into the reduced harm perspective, highlighting comparisons with smoking, which contains more toxins and carcinogens. The narrative balances harm reduction strategies like nicotine pouches and snus with the ongoing challenges of nicotine addiction and youth exposure.

The episode also emphasizes the declining popularity of vaping among U.S. high school students, dropping from 27.5% in 2019 to 19.6% in 2024. Despite this, the conversation underscores the importance of thoughtful regulation to deter youth addiction while supporting smokers transitioning away from cigarettes. Drawing on expert insights, the discussion highlights misconceptions around vaping, including its supposed role as a smoking cessation aid, while advocating for evidence-based strategies like behavioral counseling and FDA-approved cessation tools. Tune in for a balanced exploration of vaping’s evolving role in public health.

In this episode, we unpack Lyme disease, the most common vector-borne illness in the United States, caused by the bacterium Borrelia burgdorferi and transmitted through the bite of blacklegged ticks. Often underdiagnosed due to its diverse symptoms, Lyme disease can present as flu-like symptoms, rashes, or more severe complications like arthritis, facial palsy, and heart issues if left untreated. While prevalent in northeastern and upper midwestern states, cases in Texas are rare and typically result from travel to high-incidence areas.

Listeners will gain insights into the tick’s lifecycle, how Lyme disease spreads, and the importance of early diagnosis and treatment with antibiotics to prevent long-term health issues. We’ll also debunk common myths, such as misconceptions about transmission, and provide practical advice on tick prevention and removal to reduce the risk of infection. This episode offers a clear and informative look at Lyme disease for anyone seeking to better understand this complex condition.

In this episode, we uncover the essential role of preservatives in everyday life, from extending the shelf life of foods to maintaining the stability of pharmaceuticals and personal care products. We explore the science behind these natural and synthetic compounds, discussing their functions, benefits, and the challenges they address, such as preventing bacterial growth, delaying rancidity, and ensuring product safety. With examples ranging from antioxidants in foods to antimicrobial agents in medicines, we explain how these substances impact product quality and safety.

Listeners will also learn about controversies surrounding specific preservatives, including their potential health risks and misconceptions. We’ll break down myths about natural versus synthetic preservatives, highlight innovations in food and pharmaceutical preservation, and provide tips on understanding product labels. This episode offers a comprehensive look at how preservatives shape our modern world, blending science with practical insights.

In this episode, we delve into the world of CBD, a compound derived from the cannabis plant that has garnered widespread attention for its potential health benefits. From its legal history and regulatory landscape to its current uses, we explore how CBD works in the body and its role in managing conditions such as treatment-resistant epilepsy, for which it is FDA-approved. Despite its popularity, CBD’s efficacy in other areas, such as anxiety, pain relief, and sleep improvement, remains under-researched and often misunderstood.

Listeners will gain insights into the science of CBD, including its non-psychoactive properties, its interaction with the endocannabinoid system, and the challenges surrounding product quality and standardization. We’ll also address common myths, potential side effects, and the importance of informed use in a market with inconsistent labeling and safety oversight. Whether you’re curious about CBD’s medical potential or its broader societal impact, this episode provides a balanced and comprehensive perspective.

In this episode, we tackle the burning questions around heartburn and indigestion, two of the most common gastrointestinal complaints. Learn how these conditions arise, from acid reflux and weakened esophageal barriers to triggers like stress, obesity, and certain foods. We’ll also break down the symptoms, including the classic burning sensation in the chest, bloating, and belching, and explore when heartburn might signal a more serious health issue such as GERD or esophageal damage.

The discussion includes practical strategies for relief, from lifestyle modifications like dietary changes and weight loss to over-the-counter treatments such as antacids, H2 blockers, and proton pump inhibitors. With clear explanations and tips, this episode is your guide to understanding and managing these uncomfortable yet treatable conditions.

In this episode, we explore the growing popularity and science behind GLP-1 receptor agonists like semaglutide (Ozempic®, Wegovy®), medications initially developed for type 2 diabetes that have become game-changers in weight loss management. We’ll examine how these drugs work to regulate appetite, slow gastric emptying, and promote fat loss while discussing their effectiveness compared to traditional approaches. With soaring prescription rates and celebrity endorsements, GLP-1 agonists have gained attention for their transformative potential in combating obesity, a chronic condition affecting millions.

Listeners will learn about the benefits, side effects, and myths surrounding these medications, as well as the economic and accessibility challenges that patients face. We’ll also highlight the importance of combining these treatments with healthy lifestyle changes to achieve sustainable weight loss. Whether you’re curious about the science or considering options for weight management, this episode delivers a comprehensive overview for the lay audience.

In this podcast episode, we dive into the world of Respiratory Syncytial Virus (RSV), a common yet often misunderstood respiratory virus. Once primarily associated with serious infections in young children, RSV has emerged as a significant health concern for older adults and individuals with chronic conditions. We’ll explore the virus’s history, transmission, symptoms, and its seasonal patterns, which have recently shifted due to the COVID-19 pandemic. Additionally, we’ll discuss the latest advancements in prevention, including vaccines and antibody treatments, which offer hope for protecting the most vulnerable populations.

RSV affects millions annually, causing cold-like symptoms in most but potentially severe illness in high-risk groups such as premature infants and adults over 65. Join us as we unpack the science behind RSV, its impact on global health, and practical steps you can take to protect yourself and your loved ones during RSV season.